<code id='B8EB1665A7'></code><style id='B8EB1665A7'></style>
    • <acronym id='B8EB1665A7'></acronym>
      <center id='B8EB1665A7'><center id='B8EB1665A7'><tfoot id='B8EB1665A7'></tfoot></center><abbr id='B8EB1665A7'><dir id='B8EB1665A7'><tfoot id='B8EB1665A7'></tfoot><noframes id='B8EB1665A7'>

    • <optgroup id='B8EB1665A7'><strike id='B8EB1665A7'><sup id='B8EB1665A7'></sup></strike><code id='B8EB1665A7'></code></optgroup>
        1. <b id='B8EB1665A7'><label id='B8EB1665A7'><select id='B8EB1665A7'><dt id='B8EB1665A7'><span id='B8EB1665A7'></span></dt></select></label></b><u id='B8EB1665A7'></u>
          <i id='B8EB1665A7'><strike id='B8EB1665A7'><tt id='B8EB1665A7'><pre id='B8EB1665A7'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:82
          mitochondria
          Illustration of mitochondria, powerhouse of the cell. Adobe

          As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

          A study published this week in Cancer Cell investigated how cancer cells can rob mitochondria from T cells, shutting the immune cell down while energizing themselves. It may be yet another way cancer overcomes both the body’s defenses and resists many immunotherapies like CAR-T therapy and immune checkpoint blockade drugs, experts said.

          advertisement

          “This is a new mechanism of immune evasion. It seems like the cancer cells are draining mitochondria from the T cells,” said Bo Li, a cancer researcher at the University of Pennsylvania and a senior author on the paper. “It’s really amazing. Some of my colleagues, their reaction was like, ‘I can’t believe this is true.’ I understand that. It’s just like the cancer cell is too smart.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Startup Neumora takes a novel depression drug to Phase 3
          Startup Neumora takes a novel depression drug to Phase 3

          AdobeNeumora,aprivatelyheldbiotechcompany,ismovingintothefinalphaseoftestingwithanoveltreatmentforde

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Google and Epic fight stronger regulation of AI in health care

          AdobeBigbusinessespoisedtoprofitfromtheadvanceofartificialintelligenceinhealthcarearepushingbackagai